Twelve-Month Outcomes of Combined Phacoemulsification with Ab Interno Canaloplasty Versus Single-Use Dual Blade Goniotomy in Glaucoma Patients
Klinische Monatsblätter für Augenheilkunde · 01.05.2025 · 242 (05) · 562-569
DOI: 10.1055/a-2512-8141 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.05.2025. Verfasst von Julia Prinz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology/Eye Clinic, University Hospital Aachen, Germany. Hauptthemen laut MEDLINE: Phacoemulsification, Glaucoma, Trabeculectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
To compare the efficacy and safety of combined phacoemulsification with ab interno canaloplasty (Phaco-AbiC) versus single-use dual blade goniotomy (Phaco-DBG). Material and Methods In this prospective consecutive case series, intraocular pressure (IOP), the number of IOP-lowering medications, the mean deviation (MD) of visual field testing, and surgery-related complications were evaluated in 25 eyes following Phaco-AbiC and 20 eyes following Phaco-DBG through 12 months of follow-up. Qualified or complete success was defined as postoperative IOP lower than 21, 18, and 16 mmHg with or without IOP-lowering medications.
Results
At the 12-month follow-up, IOP was significantly reduced compared to baseline in the Phaco-AbiC (14.2 ± 2.7 versus 19.2 ± 4.7 mmHg, p < 0.001) and Phaco-DBG groups (16.7 ± 3.4 versus 19.9 ± 3.9 mmHg, p < 0.001). At the 12-month follow-up, IOP was significantly higher following Phaco-DBG than Phaco-AbiC (p = 0.011). Compared to baseline, the number of IOP-lowering medications was significantly reduced in the Phaco-AbiC (1.2 ± 1.4 versus 2.4 ± 1.0, p < 0.001) and Phaco-DBG groups (0.8 ± 0.9 versus 2.1 ± 0.9, p < 0.001) at the 12-month follow-up. For IOP lower than 16 mmHg, the complete and qualified success rate was significantly higher following Phaco-AbiC (36.0 and 76.2%, respectively) than Phaco-DBG (17.5 and 40.6%; p = 0.037; p = 0.007, respectively). No severe intra- or postoperative complications occurred.
Conclusion
Both Phaco-AbiC and Phaco-DBG achieved a significant reduction in IOP and IOP-lowering medications at the 12-month follow-up. IOP was significantly lower 12 months following Phaco-AbiC than Phaco-DBG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ophthalmology/Eye Clinic, University Hospital Aachen, Germany.
ORCID-Profile: Julia Prinz
Zitieren
APA
Prinz, J., Plange, N., Schellhase, H., Walter, P., Fuest, M., Koutsonas, A., & Kuerten, D. (2025). Twelve-Month Outcomes of Combined Phacoemulsification with Ab Interno Canaloplasty Versus Single-Use Dual Blade Goniotomy in Glaucoma Patients. Klinische Monatsblätter für Augenheilkunde, 242(05), 562-569. https://doi.org/10.1055/a-2512-8141
Vancouver
Prinz J, Plange N, Schellhase H, Walter P, Fuest M, Koutsonas A, et al. Twelve-Month Outcomes of Combined Phacoemulsification with Ab Interno Canaloplasty Versus Single-Use Dual Blade Goniotomy in Glaucoma Patients. Klinische Monatsblätter für Augenheilkunde. 2025;242(05):562-569. doi:10.1055/a-2512-8141
BibTeX
@article{Prinz2025,
author = {Prinz, Julia and Plange, Niklas and Schellhase, Hannah and Walter, Peter and Fuest, Matthias and Koutsonas, Antonis and Kuerten, David},
title = {Twelve-Month Outcomes of Combined Phacoemulsification with Ab Interno Canaloplasty Versus Single-Use Dual Blade Goniotomy in Glaucoma Patients},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2025},
volume = {242},
number = {05},
pages = {562--569},
doi = {10.1055/a-2512-8141}
}
EUVIMED